eServGlobal has secured US$24.9 million to support its investment into HomeSend, a JV with Mastercard
eServGlobal Limited has raised US$24.9 million to fund an expected cash call from its 35.7%-owned HomeSend joint venture. This capital requirement was originally anticipated to be funded US$59 million pro-rata by eServGlobal and the other owner, Mastercard, with the majority coming from the latter. This total was scaled back to US$55.6 million, of which an initial US$7.2 million was invested before the end of the month.
eServGlobal (Now Wameja Limited) is a pioneering digital financial transactions technology company. It enables financial and telecommunications service providers to create smoother transactions for their customers through its deep technical expertise and rapid implementation.
Oaklins Cavendish’s sister firm finnCap, based in the UK, led the global roadshow for eServGlobal’s US$24.9 million fundraising, raising capital from investors in both Europe and Australia.
Talk to the deal team
Related deals
Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn moreTekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more